Lv791
4560 积分 2023-09-17 加入
Novel therapeutic strategies in pancreatic cancer: moving beyond cytotoxic chemotherapy
5天前
已完结
Mechanisms of PARP inhibitor sensitivity and resistance
6天前
已完结
Mechanisms of PARP Inhibitor Resistance
6天前
已完结
Therapeutic Targeting of Oncogene-induced Transcription-Replication Conflicts in Pancreatic Ductal Adenocarcinoma
6天前
已完结
An update on PARP inhibitors—moving to the adjuvant setting
7天前
已完结
Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma
7天前
已完结
GRB2 stabilizes RAD51 at reversed replication forks suppressing genomic instability and innate immunity against cancer
20天前
已完结
Cancer statistics, 2024
1个月前
已完结
Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future
1个月前
已完结
METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinoma
1个月前
已完结
皖公网安备34019202002308
